tiprankstipranks
Trending News
More News >
Glenmark Life Sciences Limited (IN:GLS)
:GLS
India Market

Glenmark Life Sciences Limited (GLS) Income Statement

Compare
4 Followers

Glenmark Life Sciences Limited Income Statement

Last quarter (Q1 2025), Glenmark Life Sciences Limited's total revenue was ₹5.89B, an increase of 1.76% from the same quarter last year. In Q1, Glenmark Life Sciences Limited's net income was ₹1.11B. See Glenmark Life Sciences Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 22Dec 22Dec 21Dec 19
Total Revenue
₹ 22.83B₹ 21.61B₹ 21.23B₹ 18.85B₹ 15.37B
Gross Profit
₹ 12.43B₹ 11.47B₹ 10.80B₹ 9.80B₹ 8.47B
Operating Expenses
₹ 3.45B₹ 5.47B₹ 5.01B₹ 4.18B₹ 4.03B
Depreciation and Amortization
₹ 534.52M₹ 420.94M₹ 378.77M₹ 333.94M₹ 293.68M
EBITDA
₹ 6.86B₹ 6.71B₹ 6.31B₹ 5.92B₹ 4.84B
Operating Income
₹ 8.98B₹ 6.01B₹ 5.79B₹ 5.62B₹ 4.44B
Other Income/Expenses
₹ -2.67B₹ -2.31B₹ -2.59B₹ -2.84B₹ -2.05B
Pretax Income
₹ 6.31B₹ 6.29B₹ 5.65B₹ 4.71B₹ 4.21B
Net Income
₹ 4.71B₹ 4.67B₹ 4.19B₹ 3.52B₹ 3.13B
Per Share Metrics
Basic EPS
₹ 38.43₹ 38.11₹ 35.63₹ 32.61₹ 29.04
Diluted EPS
₹ 38.38₹ 38.11₹ 35.63₹ 32.61₹ 29.04
Weighted Average Shares Outstanding
122.53M 122.53M 117.53M 107.80M 107.80M
Weighted Average Shares Outstanding (Diluted)
122.69M 122.53M 117.53M 107.80M 107.80M
Currency in INR

Glenmark Life Sciences Limited Earnings and Revenue History